ArticleBMC infectious diseases2025
Protocol for nationwide surveillance of Acute Encephalitis Syndrome (AES) in a network of tertiary care hospitals in India.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Chandipura Virus: An Emerging Neurological Threat Transmitted by Sandflies in India.Immunity, inflammation and disease · 2026Review
- Development and Validation of a Comprehensive Acute Encephalitis Syndrome Severity Score in Children with Acute Encephalitis Syndrome.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2026Article
- A community-based focal serosurvey for West Nile virus infection following a surge in cases in 2024 in Kerala, India: a cross-sectional analysis.New microbes and new infections · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
Abstract
backgroundAdvances in laboratory diagnostics have greatly enhanced the understanding of the infectious aetiologies of Acute Encephalitis Syndrome (AES) globally. However, these diagnostic tests are not widely utilized in many public-sector clinical settings in India. Significant gaps thus remain in the knowledge and understanding of the burden, etiological spectrum, and risk factors associated with AES occurring in India.
methodsThe current manuscript outlines a protocol designed to characterize the infectious causes of AES in affected regions of India through a network of 12 selected tertiary care hospitals and their associated Virus Research and Diagnostic Laboratories (VRDLs). A standardized tiered testing algorithm accounting for a wide range of possible etiological agents of infectious AES has been developed for use in the protocol, which aims to employ serological and molecular techniques to diagnose AES-causing priority pathogens. Pathogens of interest have been grouped in the testing algorithm into five levels (Levels 1-5) in decreasing order of priority based on their reported incidence. Clinical samples from each patient will be collected at presentation at respective sites, and relevant demographic and clinical data will be obtained from hospital records. Approximately 20% of samples which test negative for Level 1-4 pathogens will be subjected to Next-Generation Sequencing (NGS) to identify less well known/rare infectious causes of AES (Level 5 pathogens). De-identified clinical and laboratory data will be recorded into a web-based portal and managed by a designated nodal laboratory responsible for coordinating and overseeing the surveillance. The protocol ensures quality laboratory testing through an External Quality and Assessment Programme (EQAP). DISCUSSION: Results from this nationwide surveillance will yield crucial data to identify the causes of Acute Encephalitis Syndrome (AES) across India, supporting targeted public health interventions that could help reduce the disease burden. Additionally, this protocol serves as a model for a tiered laboratory algorithm for AES surveillance, providing a framework to guide similar initiatives in other regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.